appengine.ai

Artificial Intelligence | Machine Learning Nucleai | AI-powered Precision Oncology Platform


Enterprise, Healthcare, Information Services, Pharma, Biomarkers, Digital Pathology Tel Aviv, TLV, Israel

Nucleai

Artificial Intelligence | Machine Learning


Nucleai | AI-powered Precision Oncology Platform

Nucleai

Healthcare, Information Services, Pharma, Biomarkers, Digital Pathology


Tel Aviv, TLV, Israel

The company is a leading provider of an AI-powered precision oncology platform transforming biomarker discovery and treatment decisions. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy, and improving patient care. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects.

 

B2B

26 to 50

Series A

$11.5 M

Scaling Up

2017

 
 

Information Services
Healthcare

N/A

N/A

 
 

IT and Security

Yes

Active

 
 

   Machine Learning


CDx

CDx

Big Data

Big Data

Biomarker Development

Biomarker Development

Digital Pathology

Digital Pathology


N/A

 

   Software


NA

NA


NA

NA

 
 
Avi Veidman


Avi Veidman
CEO

Eliron Amir


Eliron Amir
COO

Albert Achtenberg


Albert Achtenberg
CTO